CompaniesAminex Therapeutics

Aminex Therapeutics

active
Austin, TX, United States
Founded 2009
Website
About

Cancer treatment

Areas of Focus

Categories

Small Molecule PharmaceuticalSouthwestern U.S.
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

3

As Collaborator

1

Total Enrollment

360

By Phase

PHASE1/PHASE2: 2PHASE1: 2

By Status

RECRUITING: 1TERMINATED: 1WITHDRAWN: 1COMPLETED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
Today
NCT03536728
NCT06465199
Hover over trial bars to see details

Recent Trials

NCT06465199Collaborator
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
PHASE1/PHASE2Recruiting
289 participants
Started: Oct 14, 2025 · Completed: Feb 28, 2035
NCT05500508Lead Sponsor
Oral AMXT 1501 Dicaprate in Combination With IV DFMO
PHASE1/PHASE2Terminated
15 participants
Started: Nov 29, 2022 · Completed: Dec 12, 2024
NCT03077477Lead Sponsor
Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers
PHASE1Withdrawn
Started: Jun 12, 2018 · Completed: Jun 12, 2018
NCT03536728Lead Sponsor
Oral AMXT 1501 Dicaprate in Combination With DFMO
PHASE1Completed
56 participants
Started: Jun 12, 2018 · Completed: Apr 21, 2023
Funding History (5)
D
Aug 19, 2021
Filing
D
Aug 14, 2020
Filing
D
Jun 1, 2018
Filing
D
Nov 12, 2014
Filing
D
Jul 11, 2014
Filing
Locations (1)
Headquarters
Austin, TX, United States
Map

Loading map...